About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02542072

Multi-Center Clinical Evaluation of Two Reusable Soft Contact Lenses

The purpose of this study is to compare the subjective performance of comfilcon A lens against samfilcon A lens after 4 weeks of reusable lens wear.

Lead sponsor: CooperVision, Inc.•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

CooperVision, Inc.

This will be a 90 subject, randomized, bilateral, subject-masked, dispensing, cross-over study comparing comfilcon A versus samfilcon A lenses over 8 weeks of daily wear (2 x 4-weeks). Both eyes will wear the same lens (test or control) for 4 weeks in a randomized fashion. Subjects will be masked to lens type and investigators will be masked to the lens codes.

Age

18 - 50 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Inclusion:
•Spherical distance Contact Lens prescription between -1.00 and -6.00D or +1.00 to +4.00D in both eyes (inclusive)
•Adapted soft Contact Lens wearers (i.e. \>1 month), daily disposable and reusable lens wearers.
•Spectacle cylinder 0.75D in both eyes.
•Correctable to 6/9 (20/30) in both eyes
•Be between 18 and 50 years of age (inclusive)
•Able to read, comprehend and sign an informed consent
•Own a mobile phone and be willing to respond to Short Message Service (SMS) survey
•Willing to comply with the wear and study visit schedule
•Exclusion:
•Existing Biofinity or Ultra wearers
•Any active corneal infection, injury or inflammation
•Systemic or ocular allergies, which might interfere with Contact Lens wear
•Systemic disease, which might interfere with Contact Lens wear
•Ocular disease, which might interfere with Contact Lens wear
•Strabismus or amblyopia
•Subjects who have undergone corneal refractive surgery
•Subjects with keratoconus or other severe corneal irregularity contraindicating lens wear
•Pregnant or lactating
•Use of systemic/topical medication contraindicating Contact Lens wear
•Diabetic
•Site employees or family members of site employees

Related studies

Artificial Intelligence for Highly Myopic Cataract

NCT06616506 · Cataract, High Myopia, and more

Evaluation of the Effectiveness of a New Generation of Myopia Control Lens on the Progression of Myopia in Children Aged 6 to 14 Years

NCT07462897 · Myopia Progression

RECRUITINGPhase 3

The Effect of Myopia-Control Contact Lenses in New Zealand Chinese Children

NCT07535749 · Myopia Progression

Comparison of Myopic Small Incision Lenticule Extraction (SMILE) With VISUMAX 500 Versus VISUMAX 800 Platforms

NCT07505264 · Myopia

Comparing Myopia Treatments in Youth: Defocus Spectacles, Glasses, and Ortho-K

NCT06278974 · Myopia, Cost-effectiveness Analysis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 24, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment90

Start dateAug 2015

Last updatedOct 24, 2017

Condition

Locations shown

Golden Optometric Group

Whittier, California

Complete Eye Care of Medina

Medina, Minnesota

Brock & Houlford

Chew Magna, Bristol

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 24, 2017Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions